Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-28 1:39 pm Purchase | 2021-12-31 | 13G | Sierra Oncology, Inc. SRRA | Frazier Life Sciences VIII L.P. | 1,264,861 8.400% | 1,062,058 (+523.69%) | Filing History |
| 2021-11-08 07:58 am Purchase | 2021-11-03 | 13D | Sierra Oncology, Inc. SRRA | Longitude Capital Partners III LLC | 3,450,270 20.300% | 1,972,450 (+133.47%) | Filing History |
| 2021-11-05 5:00 pm Purchase | 2021-11-05 | 13G | Sierra Oncology, Inc. SRRA | Vivo Capital IX, LLC | 1,935,853 14.800% | 480,277 (+33.00%) | Filing History |
| 2021-11-05 4:40 pm Purchase | 2021-11-05 | 13D | Sierra Oncology, Inc. SRRA | Abingworth LLP | 2,043,626 12.600% | 7,874 (+0.39%) | Filing History |
| 2021-11-05 4:26 pm Purchase | 2021-11-05 | 13D | Sierra Oncology, Inc. SRRA | ORBIMED ADVISORS LLC | 3,044,753 18.100% | 3,033,090 (+26006.64%) | Filing History |
| 2021-08-16 4:17 pm Purchase | 2021-08-06 | 13G | Sierra Oncology, Inc. SRRA | Frazier Life Sciences Public Fund, L.P. | 804,667 9.500% | 804,667 (New Position) | Filing History |
| 2021-04-01 4:56 pm Purchase | 2021-03-22 | 13G | Sierra Oncology, Inc. SRRA | ADAGE CAPITAL PARTNERS GP L.L.C. | 794,140 6.830% | 794,140 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Sierra Oncology, Inc. SRRA | CAXTON CORP | 1,142,361 9.900% | 60,161 (+5.56%) | Filing History |
| 2021-02-16 4:32 pm Purchase | 2020-12-31 | 13G | Sierra Oncology, Inc. SRRA | Rock Springs Capital Management LP | 567,358 5.140% | 12,281 (+2.21%) | Filing History |
| 2021-02-16 12:06 pm Sale | 2021-01-26 | 13G | Sierra Oncology, Inc. SRRA | Mangrove Partners Master Fund Ltd. | 548,869 4.800% | -38,595 (-6.57%) | Filing History |
| 2021-02-16 12:00 pm Purchase | 2020-12-31 | 13G | Sierra Oncology, Inc. SRRA | Mangrove Partners Master Fund Ltd. | 587,464 5.100% | 587,464 (New Position) | Filing History |
| 2020-10-19 4:23 pm Purchase | 2020-10-09 | 13G | Sierra Oncology, Inc. SRRA | Rock Springs Capital Management LP | 555,077 5.340% | 555,077 (New Position) | Filing History |